Radioguided Surgery of Primary Hyperparathyroidism Using the Low-Dose 99mTc-Sestamibi Protocol: Multiinstitutional Experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS)
Domenico Rubello, MD1,
Maria Rosa Pelizzo, MD2,
Giuseppe Boni, MD3,
Riccardo Schiavo, MD4,
Luca Vaggelli, MD5,
Giuseppe Villa, MD6,
Sergio Sandrucci, MD7,
Andrea Piotto, MD2,
Gianpiero Manca, MD3,
Pierluigi Marini, MD8 and
Giuliano Mariani, MD3
1 Nuclear Medicine Service, "S. Maria della Misericordia" Hospital, Rovigo, Italy
2 Department of Surgery, University of Padua Medical School, Padua, Italy
3 Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy
4 Nuclear Medicine Service, "S. Camillo-Forlanini" Hospital, Rome, Italy
5 Nuclear Medicine Service, "Careggi" University Hospital, Florence, Italy
6 Nuclear Medicine Service, "S. Martino" University Hospital, Genoa, Italy
7 Department of Surgery, University of Turin Medical School, Turin, Italy
8 Division of Surgery, "S. Camillo-Forlanini" Hospital, Rome, Italy

View larger version (32K):
[in a new window]
|
FIGURE 1. Distribution of patients according to main factors affecting choice of surgical approach. BNE = bilateral neck exploration; T = thyroid; PT = parathyroid; MIBI = 99mTc-sestamibi.
|
|
Copyright © 2005 by the Society of Nuclear Medicine.